Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients
PURPOSEExoseal is a vascular closure device consisting of a plug applier and a bio-absorbent polyglycolic acid plug available in sizes 5 F, 6 F, and 7 F. In this study, we aimed to evaluate the effectiveness and safety of the Exoseal vascular closure device (Cordis Corporation, Bridgewater, New Jer...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2014-09-01
|
| Series: | Diagnostic and Interventional Radiology |
| Online Access: |
http://www.dirjournal.org/archives/archive-detail/article-preview/exoseal-for-puncture-site-closure-after-antegrade-/56091
|
| _version_ | 1797691399988051968 |
|---|---|
| author | Gerald Hackl Thomas Gary Klara Belaj Franz Hafner Peter Rief Hannes Deutschmann Marianne Brodmann |
| author_facet | Gerald Hackl Thomas Gary Klara Belaj Franz Hafner Peter Rief Hannes Deutschmann Marianne Brodmann |
| author_sort | Gerald Hackl |
| collection | DOAJ |
| description | PURPOSEExoseal is a vascular closure device consisting of a plug applier and a bio-absorbent polyglycolic acid plug available in sizes 5 F, 6 F, and 7 F. In this study, we aimed to evaluate the effectiveness and safety of the Exoseal vascular closure device (Cordis Corporation, Bridgewater, New Jersey, USA) for puncture site closure after antegrade endovascular procedures in peripheral arterial occlusive disease (PAOD) patients. MATERIALS AND METHODSIn this retrospective study, a total of 168 consecutive patients who underwent an interventional procedure due to PAOD, were included. In each case, an antegrade peripheral endovascular procedure was performed via the common femoral artery using the Seldinger technique, and Exoseal 5 F, 6 F, or 7 F was used for access site closure. The primary endpoint was a technically successful application of Exoseal. All complications at the access site within 24 hours were registered as a secondary endpoint.RESULTSIn a group of 168 patients (64.9% men, average age 71.9±11.9 years), the technical application of Exoseal was successful in 166 patients (98.8%). Within the first 24 hours after the procedure, 12 complications (7.2%) were recorded including, three pseudoaneurysms (1.8%) and nine hematomas (5.4%). None of the complications required surgical intervention.CONCLUSIONExoseal is a safe and effective device with high technical success and acceptable complication rates for access site closure after antegrade peripheral endovascular procedures. |
| first_indexed | 2024-03-12T02:12:46Z |
| format | Article |
| id | doaj.art-031fc620f72a4c149d91e12e6f401210 |
| institution | Directory Open Access Journal |
| issn | 1305-3825 1305-3612 |
| language | English |
| last_indexed | 2024-03-12T02:12:46Z |
| publishDate | 2014-09-01 |
| publisher | Galenos Publishing House |
| record_format | Article |
| series | Diagnostic and Interventional Radiology |
| spelling | doaj.art-031fc620f72a4c149d91e12e6f4012102023-09-06T11:25:54ZengGalenos Publishing HouseDiagnostic and Interventional Radiology1305-38251305-36122014-09-0120542643110.5152/dir.2014.1400213049054Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patientsGerald Hackl0Thomas Gary1Klara Belaj2Franz Hafner3Peter Rief4Hannes Deutschmann5Marianne Brodmann6 Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria Division of Interventional Radiology, Department of Radiology, Medical University Graz, Styria, Austria Division of Angiology, Department of Internal Medicine, Medical University Graz, Styria, Austria PURPOSEExoseal is a vascular closure device consisting of a plug applier and a bio-absorbent polyglycolic acid plug available in sizes 5 F, 6 F, and 7 F. In this study, we aimed to evaluate the effectiveness and safety of the Exoseal vascular closure device (Cordis Corporation, Bridgewater, New Jersey, USA) for puncture site closure after antegrade endovascular procedures in peripheral arterial occlusive disease (PAOD) patients. MATERIALS AND METHODSIn this retrospective study, a total of 168 consecutive patients who underwent an interventional procedure due to PAOD, were included. In each case, an antegrade peripheral endovascular procedure was performed via the common femoral artery using the Seldinger technique, and Exoseal 5 F, 6 F, or 7 F was used for access site closure. The primary endpoint was a technically successful application of Exoseal. All complications at the access site within 24 hours were registered as a secondary endpoint.RESULTSIn a group of 168 patients (64.9% men, average age 71.9±11.9 years), the technical application of Exoseal was successful in 166 patients (98.8%). Within the first 24 hours after the procedure, 12 complications (7.2%) were recorded including, three pseudoaneurysms (1.8%) and nine hematomas (5.4%). None of the complications required surgical intervention.CONCLUSIONExoseal is a safe and effective device with high technical success and acceptable complication rates for access site closure after antegrade peripheral endovascular procedures. http://www.dirjournal.org/archives/archive-detail/article-preview/exoseal-for-puncture-site-closure-after-antegrade-/56091 |
| spellingShingle | Gerald Hackl Thomas Gary Klara Belaj Franz Hafner Peter Rief Hannes Deutschmann Marianne Brodmann Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients Diagnostic and Interventional Radiology |
| title | Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| title_full | Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| title_fullStr | Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| title_full_unstemmed | Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| title_short | Exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| title_sort | exoseal for puncture site closure after antegrade procedures in peripheral arterial disease patients |
| url |
http://www.dirjournal.org/archives/archive-detail/article-preview/exoseal-for-puncture-site-closure-after-antegrade-/56091
|
| work_keys_str_mv | AT geraldhackl exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT thomasgary exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT klarabelaj exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT franzhafner exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT peterrief exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT hannesdeutschmann exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients AT mariannebrodmann exosealforpuncturesiteclosureafterantegradeproceduresinperipheralarterialdiseasepatients |